FDA nod to Boehringer Ingelheim’s JASCAYD for progressive pulmonary fibrosis in adults
The study found that nerandomilast effectively slowed lung function decline in patients, with discontinuation rates similar to placebo
The study found that nerandomilast effectively slowed lung function decline in patients, with discontinuation rates similar to placebo
This Breakthrough Therapy Designation highlights the impressive clinical benefit of Enhertu over the current standard of care
TactiFlex, the world’s first catheter with a flexible tip and contact?force sensing, allows doctors to deliver energy precisely and safely.
Full approval will depend on verification of clinical benefit in a confirmatory trial
This development marks a substantial improvement in the company's financial position and reflects strengthened promoter confidence
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Tablets will be manufactured at Granules' US-based facility located in Chantilly, Virginia
The initiative is focused on a problem that continues to plague cancer outcomes in India
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
Subscribe To Our Newsletter & Stay Updated